Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cebert Pharmaceuticals (Methadone Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The business is engaged in manufacture of Methadone HCl products for opioid addiction treatment.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Boehringer Ingelheim
Primary Office
  • 1200 Corporate Drive
  • Suite 370
  • Birmingham, AL 35242
  • United States

Cebert Pharmaceuticals (Methadone Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cebert Pharmaceuticals (Methadone Business)‘s full profile, request access.

Request full access to PitchBook

Cebert Pharmaceuticals (Methadone Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cebert Pharmaceuticals (Methadone Business)‘s full profile, request access.

Request full access to PitchBook